Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(91 sites) United States
Mayo Clinic in Arizona - Phoenix- Site Number : 8400032, Phoenix, Arizona Noble Clinical Research- Site Number : 8400003, Tucson, Arizona City of Hope National Medical Center- Site Number : 8400023, Duarte, California USC Norris Comprehensive Cancer Center- Site Number : 8400007, Los Angeles, California Stanford University Medical Center- Site Number : 8400026, Stanford, California Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center- Site Number : 8400006, Torrance, California Yale University School of Medicine- Site Number : 8400027, New Haven, Connecticut Hialeah Hospital- Site Number : 8400009, Hialeah, Florida Sylvester Comprehensive Cancer Center- Site Number : 8400031, Miami, Florida University Hospital and Medical Center- Site Number : 8400005, Tamarac, Florida University of Michigan Health System - Ann Arbor- Site Number : 8400014, Ann Arbor, Michigan Henry Ford Hospital- Site Number : 8400012, Detroit, Michigan Mayo Clinic in Rochester - Minnesota- Site Number : 8400008, Rochester, Minnesota Montefiore Medical Center - Einstein Campus- Site Number : 8400011, The Bronx, New York Ohio State University Hospital East- Site Number : 8400020, Columbus, Ohio Fox Chase Cancer Center - Philadelphia- Site Number : 8400019, Philadelphia, Pennsylvania Brown University Health - Rhode Island Hospital- Site Number : 8400028, Providence, Rhode Island Baptist Memorial Hospital- Site Number : 8400018, Memphis, Tennessee UT Health - San Antonio- Site Number : 8400015, San Antonio, Texas Gundersen Health System - La Crosse Medical Center- Site Number : 8400033, La Crosse, Wisconsin Argentina
Investigational Site Number : 0320001, Rosario, Santa Fe Province Investigational Site Number : 0320003, Buenos Aires Investigational Site Number : 0320002, Buenos Aires Austria
Investigational Site Number : 0400001, Vienna Investigational Site Number : 0400002, Vienna Brazil
Hemoes - Centro Estadual de Hemoterapia e Hematologia Marcos Daniel Santos- Site Number : 0760002, Vitória, Espírito Santo Universidade Federal de Goias- Site Number : 0760001, Goiânia, Goiás Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760003, São Paulo China
Investigational Site Number : 1560001, Beijing Investigational Site Number : 1560007, Chengde Investigational Site Number : 1560011, Guangzhou Investigational Site Number : 1560005, Guangzhou Investigational Site Number : 1560009, Hohhot Investigational Site Number : 1560003, Nanchang Investigational Site Number : 1560012, Nanchang Investigational Site Number : 1560004, Suzhou Investigational Site Number : 1560002, Tianjin Investigational Site Number : 1560010, Wuhan Investigational Site Number : 1560006, Xi'an Investigational Site Number : 1560008, Zhengzhou Czechia
Investigational Site Number : 2030002, Prague, Cardiff [Caerdydd Gb-crd] Investigational Site Number : 2030001, Brno Denmark
Investigational Site Number : 2080003, Aarhus Investigational Site Number : 2080002, Copenhagen Investigational Site Number : 2080001, Odense Germany
Investigational Site Number : 2760003, Berlin Investigational Site Number : 2760001, Essen Greece
Investigational Site Number : 3000002, Athens Investigational Site Number : 3000005, Larissa Investigational Site Number : 3000004, Pátrai Investigational Site Number : 3000003, Pátrai Investigational Site Number : 3000001, Thessaloniki Hungary
Investigational Site Number : 3480002, Debrecen Israel
Investigational Site Number : 3760001, Afula Investigational Site Number : 3760007, Haifa Investigational Site Number : 3760005, Kefar Sava Investigational Site Number : 3760002, Tel Aviv Italy
Investigational Site Number : 3800004, Florence, Firenze Investigational Site Number : 3800010, Genoa, Genova Investigational Site Number : 3800001, Milan, Milano Investigational Site Number : 3800005, Naples, Napoli Investigational Site Number : 3800002, Meldola, Reggio Emilia Investigational Site Number : 3800009, Novara Investigational Site Number : 3800006, Palermo Investigational Site Number : 3800007, Trieste Investigational Site Number : 3800008, Varese Investigational Site Number : 3800003, Vicenza Japan
Investigational Site Number : 3920007, Nagoya, Aichi-ken Investigational Site Number : 3920013, Tsuchiura, Ibaraki Investigational Site Number : 3920006, Kanazawa, Ishikawa-ken Investigational Site Number : 3920012, Fujisawa, Kanagawa Investigational Site Number : 3920003, Suita, Osaka Investigational Site Number : 3920001, Iruma, Saitama Investigational Site Number : 3920010, Kofu, Yamanashi Investigational Site Number : 3920015, Fukuoka Investigational Site Number : 3920002, Fukushima Investigational Site Number : 3920014, Kyoto Investigational Site Number : 3920008, Okayama Investigational Site Number : 3920004, Tokushima Investigational Site Number : 3920005, Yamagata Netherlands
Investigational Site Number : 5280002, Amsterdam Investigational Site Number : 5280003, Leiden Poland
Investigational Site Number : 6160005, Bydgoszcz, Kuyavian-Pomeranian Voivodeship Investigational Site Number : 6160006, Lodz, Lódzkie Spain
Investigational Site Number : 7240005, Barakaldo, Basque Country Investigational Site Number : 7240001, Barcelona, Catalunya [Cataluña] Investigational Site Number : 7240007, Majadahonda, Madrid Investigational Site Number : 7240003, Seville, Sevilla Investigational Site Number : 7240004, Madrid Sweden
Investigational Site Number : 7520001, Huddinge Investigational Site Number : 7520003, Malmo